223109755	223109755	CD	B-NP	O
|	|	NN	I-NP	O
NH	NH	NN	I-NP	O
|	|	NN	I-NP	O
89517892	89517892	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
321682	321682	CD	B-NP	O
|	|	CC	I-NP	O
4/19/1997	4/19/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/1997	10/28/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/1/1997	10/1/1997	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
55	55	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
psychiatric	psychiatric	JJ	I-NP	O
history	history	NN	I-NP	O
including	include	VBG	B-PP	O
mania	mania	NN	B-NP	O
,	,	,	I-NP	O
depression	depression	NN	I-NP	O
and	and	CC	I-NP	O
psychosis	psychosis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
include	include	VBP	B-VP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
chemical	chemical	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
Ler	Ler	NNP	B-NP	O
Dition	Dition	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
questionable	questionable	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
asthma	asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
with	with	IN	B-PP	O
intubation	intubation	NN	B-NP	O
.	.	.	O	O

Catheterization	Catheterization	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wedge	wedge	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
on	on	IN	B-PP	O
LV	LV	NN	B-NP	O
gram	gram	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
nonQ-wave	nonQ-wave	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
CKs	CK	NNS	B-NP	B-protein
approximately	approximately	RB	B-NP	O
300	300	CD	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
another	another	DT	B-NP	O
nonQ-wave	nonQ-wave	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
700	700	CD	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
7	7	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
nine	nine	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
and	and	CC	O	O
F	F	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reached	reach	VBD	B-VP	O
maximum	maximum	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
137	137	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
186/80	186/80	CD	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
,	,	,	I-NP	O
multiple	multiple	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
asthma	asthma	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
flares	flare	NNS	I-NP	O
and	and	CC	O	O
rule	rule	VB	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
;	;	:	O	O
each	each	DT	B-NP	O
time	time	NN	I-NP	O
ruling	rule	VBG	B-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

In	In	IN	B-PP	O
28	28	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
vasovagal	vasovagal	JJ	B-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
atropine	atropine	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
12	12	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
thallium	thallium	NN	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
four	four	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
164/80	164/80	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
ectopy	ectopy	NN	B-NP	O
or	or	CC	O	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
questionable	questionable	JJ	B-NP	O
old	old	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
or	or	CC	I-NP	O
ischemia	ischemia	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
thallium	thallium	NN	I-NP	O
images	image	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
9	9	CD	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
Sampf	Sampf	NNP	B-NP	O
.	.	.	O	O

And	And	CC	O	O
Memorial	Memorial	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
not	not	RB	B-ADJP	O
competent	competent	JJ	I-ADJP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
such	such	JJ	B-NP	O
.	.	.	O	O

Then	Then	RB	O	O
his	his	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBN	B-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
competent	competent	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
refuse	refuse	VB	I-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
Sidegreen	Sidegreen	NNP	B-NP	O
Louw	Louw	NNP	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
to	to	TO	B-PP	O
Elkhays	Elkhays	NNP	B-NP	O
Healthcare	Healthcare	NNP	I-NP	O
after	after	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
and	and	CC	O	O
coughing	cough	VBG	B-VP	O
up	up	RP	B-PRT	O
green-brown	green-brown	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
jaw	jaw	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
lasted	last	VBN	B-VP	O
for	for	IN	B-PP	O
hours	hour	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RB	B-ADVP	O
at	at	IN	B-PP	O
Rock	Rock	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
0.5	0.5	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V4	V4	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
there	there	RB	B-ADVP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
with	with	IN	B-PP	O
nitropaste	nitropaste	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
Dely	Dely	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
aminophylline	aminophylline	NN	B-NP	O
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	B-protein
IV	IV	CD	B-NP	I-protein
drips	drip	NNS	I-NP	I-protein
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Admission	Admission	NN	B-NP	O
-	-	HYPH	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
-	-	HYPH	O	O
98.1	98.1	CD	B-NP	O
temperature	temperature	NN	I-NP	O
,	,	,	O	O
84	84	CD	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
146/82	146/82	CD	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
sat	sit	VBD	B-VP	O
was	be	VBD	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
labored	labor	VBN	I-VP	O
breathing	breathing	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pulsations	pulsation	NNS	I-NP	O
were	be	VBD	B-VP	O
visible	visible	JJ	B-ADJP	O
approximately	approximately	RB	B-NP	O
3	3	CD	I-NP	O
cm	cm	NN	I-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
angle	angle	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
,	,	,	I-NP	O
diffuse	diffuse	JJ	I-NP	O
wheezing	wheezing	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
-	-	HYPH	I-NP	O
Sounds	Sound	NNPS	I-NP	O
were	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
distant	distant	JJ	I-ADJP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
precordium	precordium	NN	I-NP	O
although	although	IN	B-SBAR	O
audible	audible	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
epigastrium	epigastrium	NN	I-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
gallops	gallop	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
rate	rate	NN	B-NP	O
of	of	IN	B-PP	O
speech	speech	NN	B-NP	O
and	and	CC	O	O
rapid	rapid	JJ	B-NP	O
thoughts	thought	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Admission	Admission	NN	B-NP	O
-	-	HYPH	O	O
141	141	CD	B-NP	O
sodium	sodium	NN	I-NP	O
,	,	,	O	O
4.1	4.1	CD	B-NP	O
potassium	potassium	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
chloride	chloride	NN	I-NP	O
,	,	,	O	O
27	27	CD	B-NP	O
bicarb	bicarb	NN	I-NP	O
,	,	,	O	O
118	118	CD	B-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
26/1	26/1	CD	B-NP	O
.2	.2	NN	I-NP	O
,	,	,	O	O
BUN/creatinine	BUN/creatinine	NN	B-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
10.39	10.39	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
44.1	44.1	CD	I-NP	I-protein
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
190	190	CD	I-NP	I-protein
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
.	.	.	O	O

troponin	troponin	NN	B-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
was	be	VBD	B-VP	O
9.5	9.5	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.2	2.2	CD	I-NP	O
,	,	,	O	O
valproic	valproic	JJ	B-NP	O
acid	acid	NN	I-NP	O
42	42	CD	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
68	68	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
axis	axis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
R-wave	R-wave	NN	I-NP	O
progression	progression	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Intervals	Interval	NNS	B-NP	O
are	be	VBP	B-VP	O
0.128	0.128	CD	B-NP	O
,	,	,	I-NP	O
0.96	0.96	CD	I-NP	O
,	,	,	I-NP	O
0.394	0.394	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
inverted	invert	VBN	I-VP	O
Ts	T	NNS	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	O	O
L	L	NN	B-NP	O
and	and	CC	O	O
nonspecific	nonspecific	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
throughout	throughout	IN	B-ADVP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
0.5	0.5	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
inferior	inferior	JJ	I-NP	O
leads	lead	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
declined	decline	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
asking	ask	VBG	B-VP	O
about	about	IN	B-PP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
test	test	NN	I-NP	O
first	first	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
his	his	PRP$	B-NP	O
sputum	sputum	NN	I-NP	B-protein
gram	gram	NN	I-NP	I-protein
stain	stain	NN	I-NP	I-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
gram	gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
and	and	CC	O	O
gram	gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
rods	rod	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
cefuroxime	cefuroxime	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	I-NP	O
aminophylline	aminophylline	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
mainly	mainly	RB	B-ADVP	O
for	for	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
induced	induced	JJ	I-NP	O
psychosis	psychosis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
inhaled	inhale	VBN	B-NP	O
steroids	steroid	NNS	I-NP	O
and	and	CC	O	O
Albuterol	Albuterol	NN	B-NP	O
and	and	CC	I-NP	O
Azmacort	Azmacort	NN	I-NP	O
via	via	IN	B-PP	O
nebulization	nebulization	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
improved	improve	VBD	B-VP	O
his	his	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
flows	flow	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
approximately	approximately	RB	B-ADVP	O
250	250	CD	B-NP	O
;	;	:	O	O
discharge	discharge	NN	B-NP	O
peak	peak	NN	I-NP	O
flows	flow	NNS	I-NP	O
were	be	VBD	B-VP	O
between	between	IN	B-PP	O
500	500	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
700	700	CD	I-NP	I-DNA
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
one	one	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
on	on	IN	B-PP	O
top	top	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
half	half	JJ	I-NP	O
mm	mm	NN	I-NP	O
baseline	baseline	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
leads	lead	NNS	I-NP	O
,	,	,	O	O
potentially	potentially	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
although	although	IN	B-SBAR	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
echo	echo	JJ	I-NP	O
images	image	NNS	I-NP	O
were	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
during	during	IN	B-PP	O
exercise	exercise	NN	B-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-VP	O
rest	rest	VB	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
me	me	PRP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ollie	Ollie	NNP	I-NP	O
Mcclamma	Mcclamma	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Villecoconess-penmont	Villecoconess-penmont	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
50	50	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Cogentin	Cogentin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
p.m.	p.m.	FW	I-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
90	90	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Depakote	Depakote	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
p.m.	p.m.	NN	I-NP	O
Ativan	Ativan	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Trilafon	Trilafon	NN	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Azmacort	Azmacort	NNP	B-NP	O
four	four	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
,	,	,	O	O
olanzapine	olanzapine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Albuterol	Albuterol	NNP	B-NP	O
MDI	MDI	NNP	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	NN	B-NP	O
and	and	CC	O	O
p.r.n.	p.r.n.	NN	B-NP	O
Azmacort	Azmacort	NNP	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
Dictated	Dictated	NNP	B-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
JAN	JAN	NNP	B-NP	O
DWANE	DWANE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ZZ36	ZZ36	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LUIS	LUIS	NNP	B-NP	O
R.	R.	NNP	I-NP	O
BUETOW	BUETOW	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LR4	LR4	NNP	I-NP	B-protein
YT480/0613	YT480/0613	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
5276	5276	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

PYVU976H95	PYVU976H95	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/3/97	1/3/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/3/97	1/3/97	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ERLPIPE	ERLPIPE	NN	B-NP	O
HEALTH	HEALTH	NN	I-NP	O
FAX	FAX	NN	I-NP	O
102-006-8124	102-006-8124	CD	I-NP	O
ATTENTION	ATTENTION	NN	I-NP	O
:	:	:	O	O
MONROE	MONROE	NNP	B-NP	O
PODESZWA	PODESZWA	NNP	I-NP	O

